Immuneering Corporation (IMRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 161.41B | 176.25M | 229.1M | 27.73M | 38.21M | 39.59M | 55.26M | 63.69M | 74.45M | 89.08M | 100.58M | 111.51M |
| Cash & Short-Term Investments | 156.69B | 172.83M | 227.56M | 26.36M | 35.87M | 36.14M | 50.66M | 59.73M | 71.28M | 85.67M | 97.24M | 108.99M |
| Cash Only | 47.32B | 128.65M | 227.56M | 26.36M | 35.87M | 36.14M | 45.21M | 59.73M | 66.29M | 59.41M | 68.04M | 104.02M |
| Short-Term Investments | 109.37B | 44.19M | 0 | 0 | 0 | 0 | 5.45M | 0 | 4.99M | 26.26M | 29.2M | 4.97M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.72B | 3.41M | 1.54M | 1.37M | 2.34M | 3.44M | 4.6M | 3.96M | 3.17M | 3.42M | -760 | 2.52M |
| Total Non-Current Assets | 53.4B | 55.74M | 11.95M | 12.33M | 12.48M | 13.13M | 13.3M | 13.4M | 13.54M | 13.5M | 13.3M | 13.39M |
| Property, Plant & Equipment | 4.17B | 4.26M | 4.3M | 4.46M | 4.63M | 4.79M | 4.95M | 5.12M | 5.25M | 5.4M | 5.48M | 5.56M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 6.69B | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M |
| Intangible Assets | 313.83M | 321.15K | 328.46K | 335.78K | 343.1K | 350.41K | 357.73K | 365.05K | 372.36K | 379.68K | 387K | 394.31K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 42.23B | 44.47M | 631.3K | 841.73K | 810.89K | 1.3M | 1.3M | 1.23M | 1.22M | 1.03M | 743.52K | 743.7K |
| Total Assets | 214.81B | 231.99M | 241.06M | 40.06M | 50.68M | 52.71M | 68.56M | 77.09M | 87.98M | 102.58M | 113.88M | 124.9M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 423744.3% | 340.08% | 251.61% | -48.04% | -42.4% | -48.61% | -39.8% | -38.28% | -18.3% | -16.17% | -14.82% | -12.08% |
| Total Current Liabilities | 4.97B | 10.07M | 9.55M | 7.49M | 5.11M | 7.5M | 6.92M | 6.78M | 5.18M | 7.85M | 5.62M | 5.48M |
| Accounts Payable | 1.45B | 1.54M | 1.6M | 2.4M | 1.31M | 1.96M | 1.94M | 2.62M | 2.27M | 2.11M | 1.94M | 2.69M |
| Days Payables Outstanding | 362.71K | 235.96 | - | - | - | 1.03K | - | - | - | 1.01K | - | 1.27K |
| Short-Term Debt | 412.83M | 397.1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.11B | 8.13M | 7.56M | 2.04M | 1.02M | 3.82M | 2.76M | 1.89M | 1.14M | 3.89M | 80.5K | 1.79M |
| Current Ratio | 32.45x | 17.50x | 24.00x | 3.70x | 7.48x | 5.28x | 7.99x | 9.39x | 14.38x | 11.35x | 17.89x | 20.35x |
| Quick Ratio | 32.45x | 17.50x | 24.00x | 3.70x | 7.48x | 5.28x | 7.99x | 9.39x | 14.38x | 11.35x | 17.89x | 20.35x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.32B | 3.43M | 3.53M | 3.63M | 3.73M | 3.82M | 3.92M | 4M | 4.08M | 4.16M | 4.24M | 4.31M |
| Long-Term Debt | 3.32B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 3.43M | 3.53M | 3.63M | 3.73M | 3.82M | 3.92M | 4M | 4.08M | 4.16M | 4.24M | 4.31M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -302 | 0 |
| Total Liabilities | 8.29B | 13.5M | 13.08M | 11.12M | 8.84M | 11.33M | 10.84M | 10.78M | 9.26M | 12.01M | 9.86M | 9.79M |
| Total Debt | 3.73B | 3.82M | 3.92M | 4M | 4.08M | 4.16M | 4.24M | 4.31M | 4.38M | 4.46M | 4.54M | 4.64M |
| Net Debt | -43.59B | -124.82M | -223.65M | -22.35M | -31.78M | -31.98M | -40.96M | -55.42M | -61.91M | -54.94M | -63.5M | -99.37M |
| Debt / Equity | 0.02x | 0.02x | 0.02x | 0.14x | 0.10x | 0.10x | 0.07x | 0.07x | 0.06x | 0.05x | 0.04x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 206.52B | 218.48M | 227.98M | 28.94M | 41.84M | 41.39M | 57.72M | 66.31M | 78.72M | 90.58M | 104.02M | 115.1M |
| Equity Growth % | 493455.83% | 427.91% | 294.96% | -56.36% | -46.85% | -54.31% | -44.51% | -42.4% | -19.5% | -17.55% | -14.67% | -13.84% |
| Book Value per Share | 4692.33 | 4.96 | 5.75 | 0.80 | 1.18 | 1.33 | 1.93 | 2.24 | 2.68 | 3.09 | 3.55 | 4.02 |
| Total Shareholders' Equity | 206.52B | 218.48M | 227.98M | 28.94M | 41.84M | 41.39M | 57.72M | 66.31M | 78.72M | 90.58M | 104.02M | 115.1M |
| Common Stock | 64.69M | 64.65K | 63.48K | 35.99K | 35.98K | 31.05K | 31.05K | 29.65K | 29.65K | 29.27K | 29.27K | 29.26K |
| Retained Earnings | -293.78B | -280.32M | -268.74M | -253.78M | -239.34M | -224.3M | -206.24M | -191.65M | -177.57M | -163.26M | -148.18M | -135.58M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -241M | 81.33K | 0 | 0 | 0 | 0 | 7.84K | 0 | -1.08K | -778 | 5.61K | -2.22K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |